Tag
48 articles
Greater Manchester becomes the first English county to reject a £100 million health care contract with Palantir, citing concerns over data privacy and the company's controversial track record.
This article explains the fundamental data limitations that constrain AI's ability to cure cancer, exploring how insufficient data quality and quantity prevent AI systems from making reliable clinical predictions.
Samsung Research America has unveiled two AI foundation models designed to analyze wearable biosignal data, marking a significant step toward personalized health monitoring.
Over a billion people worldwide suffer from fatty liver disease, a condition that can lead to severe health complications. Researchers are now using AI tools to detect the disease early, potentially saving lives.
PRISM2, a new AI model developed by Paige and Microsoft, interprets pathology slides by combining clinical dialogue with tissue analysis for more accurate diagnostics.
Nvidia introduces a new Medical Physics Simulation framework to help healthcare robots learn through physical interaction, addressing data limitations in robotics training.
US public health agencies will test OpenAI and Anthropic AI models through a new program called PULSE, aiming to enhance public health outcomes through real-world applications.
French startup Raidium has launched its AI-native radiology platform in the U.S. at Moffitt Cancer Center, marking a significant step toward AI-first medical imaging solutions.
This article explains the concept of AI governance in healthcare and why Europe's lack of health-specific AI strategies poses significant risks to patient safety and global health equity.
Neko Health raises $700M in Series C funding, valuing the company at nearly $7 billion, and prepares to expand into New York with support from high-profile investors.
Learn how artificial intelligence is revolutionizing drug discovery by helping scientists find new medicines faster and more efficiently than ever before.
AWS and Bluesight have developed an AI solution, Prism, to help hospitals manage 340B compliance. The system integrates pharmacy and compliance data, and is now generally available across 20 health systems.
